These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31324552)

  • 1. Hepatitis E Virus Infection in Blood Donors and Risk to Patients in the United States and Canada.
    Delage G; Fearon M; Gregoire Y; Hogema BM; Custer B; Scalia V; Hawes G; Bernier F; Nguyen ML; Stramer SL
    Transfus Med Rev; 2019 Jul; 33(3):139-145. PubMed ID: 31324552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening.
    Harvala H; Hewitt PE; Reynolds C; Pearson C; Haywood B; Tettmar KI; Ushiro-Lumb I; Brailsford SR; Tedder R; Ijaz S
    Euro Surveill; 2019 Mar; 24(10):. PubMed ID: 30862338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients.
    Westhölter D; Hiller J; Denzer U; Polywka S; Ayuk F; Rybczynski M; Horvatits T; Gundlach S; Blöcker J; Schulze Zur Wiesch J; Fischer N; Addo MM; Peine S; Göke B; Lohse AW; Lütgehetmann M; Pischke S
    J Hepatol; 2018 Jul; 69(1):36-42. PubMed ID: 29551705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018-2020.
    Niederhauser C; Gowland P; Widmer N; Amar El Dusouqui S; Mattle-Greminger M; Gottschalk J; Frey BM
    Viruses; 2024 May; 16(5):. PubMed ID: 38793625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis E Virus in the United States and Canada: Is It Time to Consider Blood Donation Screening?
    Bienz M; Renaud C; Liu JR; Wong P; Pelletier P
    Transfus Med Rev; 2024 Jul; 38(3):150835. PubMed ID: 39059853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E and blood donation safety in selected European countries: a shift to screening?
    Domanović D; Tedder R; Blümel J; Zaaijer H; Gallian P; Niederhauser C; Sauleda Oliveras S; O'Riordan J; Boland F; Harritshøj L; Nascimento MSJ; Ciccaglione AR; Politis C; Adlhoch C; Flan B; Oualikene-Gonin W; Rautmann G; Strengers P; Hewitt P
    Euro Surveill; 2017 Apr; 22(16):. PubMed ID: 28449730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.
    Hewitt PE; Ijaz S; Brailsford SR; Brett R; Dicks S; Haywood B; Kennedy IT; Kitchen A; Patel P; Poh J; Russell K; Tettmar KI; Tossell J; Ushiro-Lumb I; Tedder RS
    Lancet; 2014 Nov; 384(9956):1766-73. PubMed ID: 25078306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis E virus: Blood transfusion implications].
    Gallian P; Piquet Y; Assal A; Djoudi R; Chiaroni J; Izopet J; Tiberghien P
    Transfus Clin Biol; 2014 Nov; 21(4-5):173-7. PubMed ID: 25267201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of a transfusion emergent risk: the case of HEV].
    Pillonel J; Gallian P; Sommen C; Couturier E; Piquet Y; Djoudi R; Laperche S;
    Transfus Clin Biol; 2014 Nov; 21(4-5):162-6. PubMed ID: 25267205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening the Blood Supply for Zika Virus in the 50 U.S. States and Puerto Rico: A Cost-Effectiveness Analysis.
    Russell WA; Stramer SL; Busch MP; Custer B
    Ann Intern Med; 2019 Feb; 170(3):164-174. PubMed ID: 30615781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands.
    de Vos AS; Janssen MP; Zaaijer HL; Hogema BM
    Transfusion; 2017 Feb; 57(2):258-266. PubMed ID: 28144956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis E virus in Spanish donors and the necessity for screening.
    Rivero-Juarez A; Jarilla-Fernandez M; Frias M; Madrigal-Sanchez E; López-López P; Andújar-Troncoso G; Machuca I; Camacho A; Muñoz-Valbuena P; Rivero A
    J Viral Hepat; 2019 May; 26(5):603-608. PubMed ID: 30661278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors.
    Harritshøj LH; Holm DK; Saekmose SG; Jensen BA; Hogema BM; Fischer TK; Midgley SE; Krog JS; Erikstrup C; Ullum H
    Transfusion; 2016 Sep; 56(9):2225-32. PubMed ID: 27385646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation.
    Ankcorn MJ; Tedder RS; Cairns J; Sandmann FG
    Value Health; 2020 Mar; 23(3):309-318. PubMed ID: 32197726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland.
    Grabarczyk P; Sulkowska E; Gdowska J; Kopacz A; Liszewski G; Kubicka-Russel D; Baylis SA; Corman VM; Noceń E; Piotrowski D; Antoniewicz-Papis J; Łętowska M
    Transfusion; 2018 May; 58(5):1245-1253. PubMed ID: 29492976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
    Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors.
    Stramer SL; Moritz ED; Foster GA; Ong E; Linnen JM; Hogema BM; Mak M; Chia CP; Dodd RY
    Transfusion; 2016 Feb; 56(2):481-8. PubMed ID: 26434952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy.
    Puttini C; Riccio ML; Redi D; Tordini G; Cenerini M; Romanello F; De Luca A; Carmellini M; Fossombroni V; Cusi MG; Zanelli G
    Infez Med; 2015 Sep; 23(3):253-6. PubMed ID: 26397295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E virus RNA in Australian blood donations.
    Shrestha AC; Flower RL; Seed CR; Keller AJ; Harley R; Chan HT; Hoad V; Warrilow D; Northill J; Holmberg JA; Faddy HM
    Transfusion; 2016 Dec; 56(12):3086-3093. PubMed ID: 27667133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France.
    Pillonel J; Maugard C; Sommen C; Figoni J; Pierre C; LeCam S; Richard P; Morel P; Gallian P; Laperche S
    Vox Sang; 2022 Dec; 117(12):1411-1414. PubMed ID: 36394899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.